This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cerner Appoints Zane Burke As President

Stocks in this article: CERN

KANSAS CITY, Mo., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Cerner today announced that Zane M. Burke has been named as the company's President. Mr. Burke will report to Cerner Co-Founder, Chairman and CEO Neal Patterson.

"I am very pleased to announce the appointment of Zane as president of Cerner," said Neal Patterson. "There are very few people who understand the extensive role information technology is playing in health care worldwide as well as Zane. We have a big decade ahead as we work to set new standards of excellence for our clients' organizations. Strong fundamentals are pressuring health care organizations around the world to become more accountable for the health of defined populations, resulting in a greater role for information technology as our platforms expand to include population health management. Zane has had a big part in our success to date, and in his new role he will help drive our future success."

Mr. Burke came to Cerner in 1996 from KPMG LLP, and has made significant contributions to Cerner's growth and in building strategic relationships with many of the largest health systems in the world. He has held a number of positions in the company, including President of Cerner West from 2003 to 2011, and, more recently, Executive Vice President of Cerner's client organization. Mr. Burke holds an MBA and Bachelor of Science degree in accounting from Kansas State University.

"I am excited for the opportunity to expand my leadership role at Cerner," said Zane Burke. "I believe no company is better positioned than Cerner to benefit from the current trends in health care. Our significant investments in research and development have helped drive the digitization of health care. We are poised for another era of growth with continued investments in R&D focused on leveraging this digitized data to improve health care delivery and the health of populations."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs